


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.28%
+0.45%
+4.05%
+1.23%
BNTX
BioNTech
$108.88
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value
BNTX Price Performance
$96.85 (+12.42%)
$103.43 (+5.27%)
$102.09 (+6.65%)
$122.75 (-11.30%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
BNTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BNTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
BNTX has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Recent Upgrades and Downgrades
BUY
Date
Action
Rating
Firm
Jan 30, 2026
Upgrade
Buy
Goldman Sachs
Jan 16, 2026
Upgrade
Buy
Goldman Sachs
Dec 11, 2025
Reiterate
Buy
Clear Street
Nov 10, 2025
Reiterate
Buy
HC Wainwright & Co.
Nov 07, 2025
Reiterate
Neutral
UBS
EXEL
Exelixis
42.81
+3.51%
CRSP
CRISPR Therapeutics
51.31
+2.70%
BIIB
Biogen
179.09
-0.44%
AMGN
Amgen
344.79
+0.85%
BNTX
BioNTech
108.88
-4.28%
REI
Ring Energy
1.14
-4.20%
CVNA
Carvana Co.
407.89
+1.76%
TSLA
Tesla
421.91
-1.98%
EMR
Emerson Electric Company
148.63
+1.14%
What is BNTX current stock price?
What are BNTX stock strengths?
What is BNTX Risk Level?
What is BNTX market cap and volume?
What is BNTX current Stock IQ?
Should I buy BNTX stock right now?
Is BNTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BNTX?
What does a 'Strong Sell' rating mean for BNTX?
What factors influence BNTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.28%
+0.45%
+4.05%
+1.23%
BNTX
BioNTech
Current Price
$108.88
Linked to BNTX
EXEL
Exelixis
42.81
+3.51%
CRSP
CRISPR Therapeutics
51.31
+2.70%
BIIB
Biogen
179.09
-0.44%
AMGN
Amgen
344.79
+0.85%
Recently Viewed
BNTX
BioNTech
108.88
-4.28%
REI
Ring Energy
1.14
-4.20%
CVNA
Carvana Co.
407.89
+1.76%
TSLA
Tesla
421.91
-1.98%
EMR
Emerson Electric Company
148.63
+1.14%

BNTX Price Performance
$96.85 (+12.42%)
$103.43 (+5.27%)
$102.09 (+6.65%)
$122.75 (-11.30%)
BNTX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
BNTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BNTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
BNTX has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
BUY
Jan 30, 2026
Upgrade
Buy
Goldman Sachs
Jan 16, 2026
Upgrade
Buy
Goldman Sachs
Dec 11, 2025
Reiterate
Buy
Clear Street
Nov 10, 2025
Reiterate
Buy
HC Wainwright & Co.
Nov 07, 2025
Reiterate
Neutral
UBS
BNTX Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value
BNTX Latest Analysis
Goldman Sachs Highlights BioNTechs (BNTX) Immuno-Oncology and ADC Pipeline. BioNTech SE (NASDAQ:BNTX) ranks among the best high growth European stocks to buy. On January 16 Goldman Sachs upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy and boosted its price target from $115 to $142 highlighting the companys key position in oncology. According to the firm BioNTech SE (NASDAQ:BNTX) stands at the nexus of significant [….]
Fri Jan 30, 2026
BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock?. BioNTech (BNTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Thu Jan 22, 2026
Goldman Sachs Upgrades BioNTech SE - Depositary Receipt (BNTX). Fintel reports that on January 16 2026 Goldman Sachs upgraded their outlook for BioNTech SE - Depositary Receipt (NasdaqGS:BNTX) from Neutral to Buy. Analyst Price Forecast Suggests 31.43% Upside
Fri Jan 16, 2026
Unpacking the Latest Options Trading Trends in BioNTech. High-rolling investors have positioned themselves ish on BioNTech (NASDAQ:) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in BNTX often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 20 options trad
Fri Jan 16, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BNTX Stock trends
BNTX Stock performance
BNTX Stock analysis
BNTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.